Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains ...
Topline final safety and efficacy results for the full 36 weeks of treatment from all participants will be available in ...
Modified endotracheal tubes designed to reduce patient pneumonia risk failed to improve outcomes compared to standard ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...
Introduction Nasogastric tubes (NGTs) are standard practice in the management of adhesive small bowel obstruction (ASBO). Their insertion can be associated with significant patient discomfort and ...
3don MSNOpinion
Why you should be pleased we run trials on nudges, even if you don't like nudges (or trials)
Last year, we ran a randomized controlled trial working with frontline workers in the homelessness sector, which aimed to ...
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of ...
For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback